Pharma Journalist 8801 posts 0 comments

Merck, known as MSD outside the United States and Canada, announced the completion of the acquisition of Themis, a privately-held company focused on vaccines and immune-modulation…
Read More...

SMi reports: West Pharmaceutical Services to Host a Free Exclusive Webinar on Prefilled Syringe Elastomer Components High-Quality Solutions for Sensitive Molecules, taking place on 16th…
Read More...

Tonix Pharmaceuticals Holding Corp. announced an expansion of its strategic collaboration with Southern Research to include a study of T cell immune responses to SARS-CoV-2 in…
Read More...

Alpine Immune Sciences, Inc. and AbbVie Inc. announced an exclusive worldwide option and license agreement for ALPN-101, a first-in-class dual CD28/ICOS costimulation antagonist.…
Read More...

Sarepta Therapeutics and Selecta Biosciences, Inc. announced that they have entered into a Research License and Option agreement granting Sarepta an option to license the rights to…
Read More...

Roche announced that the Phase III IMpassion031 study, evaluating Tecentriq (atezolizumab) in combination with chemotherapy (Abraxane, albumin-bound paclitaxel; nab-paclitaxel; followed…
Read More...

Neurocrine Biosciences, Inc. and Takeda Pharmaceutical Company Limited announced a strategic collaboration to develop and commercialize compounds in Takeda’s early-to-mid-stage…
Read More...

Novartis announced that the US Food and Drug Administration (FDA) has approved Cosentyx (secukinumab) for the treatment of active non-radiographic axial spondyloarthritis (nr-axSpA),…
Read More...

Orca Bio, a clinical-stage biotechnology company developing high precision allogeneic cell therapies, announced a Series D financing that brings its total capital raised since its 2016…
Read More...

Cell-based cancer vaccines are revolutionizing the treatment of previously incurable cancers. Access to these promising therapies is limited by the high costs of manufacturing at…
Read More...